Estimaciones de analistas de Wall Street para iSpecimen Inc. (ISPC): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Consenso de analistas
| Compra fuerte | 0 |
| Compra | 2 |
| Mantener | 0 |
| Venta | 0 |
| Venta fuerte | 0 |
| Analistas totales | 2 |
| Calificación media (1-5) | 1.00 |
Ratios de valoración
| Precio / Valor contable | 1.10 |
| EV / EBITDA | 0.39 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Ingresos | $4.4M | $4.3M | $8.2M | $11.1M | $10.4M | $9.9M | $9.3M | $1.9M |
| Coste de Ventas | $2.4M | $2.1M | $3.6M | $5.2M | $4.8M | $4.8M | $5.3M | $1.9M |
| Beneficio Bruto | $2.0M | $2.2M | $4.6M | $5.9M | $5.6M | $5.1M | $4.0M | $24110 |
| I+D | $1.2M | $993329 | $1.5M | $1.8M | $2.7M | $3.6M | $3.5M | $2.2M |
| Generales y Administrativos | $3.5M | $4.3M | $5.0M | $9.4M | $12.4M | $11.7M | $12.6M | $6.6M |
| Gastos Operativos | $5.4M | $6.1M | $7.0M | $11.8M | $15.8M | $16.3M | $16.7M | $9.0M |
| Beneficio Operativo | -$3.4M | -$3.9M | -$2.4M | -$5.9M | -$10.2M | -$11.2M | -$12.7M | -$9.0M |
| EBITDA | -$3.8M | -$2.5M | -$1.7M | -$5.9M | -$8.8M | -$8.8M | -$10.4M | -$8.7M |
| Gastos por Intereses | $1.2M | $1.7M | $2.1M | $2.1M | $238963 | $230785 | $220074 | $1949 |
| Beneficio Antes de Impuestos | -$5.5M | -$4.9M | -$4.7M | -$9.0M | -$10.2M | -$11.1M | -$12.5M | -$10.5M |
| Impuestos | -$127000 | -$157000 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$5.3M | -$4.7M | -$4.7M | -$9.0M | -$10.2M | -$11.1M | -$12.5M | -$10.5M |
| BPA | $-651.51 | $-575.97 | $-566.83 | $-820.91 | $-926.78 | $-982.11 | $-703.26 | $-91.15 |
| BPA Diluido | $-651.51 | $-575.97 | $-566.83 | $-820.91 | $-926.78 | $-982.11 | $-703.26 | $-91.15 |
| Acciones en Circulación (Diluidas) | $8207 | $8207 | $8207 | $10916 | $11055 | $11301 | $17771 | $115061 |
Precio
| Precio | $1.37 |
| Capitalización | $0M |
| Bolsa | NASDAQ |
| País | US |
Empresas relacionadas: BIAF · BIVI · BJDX · GLMD · HSCS · NDRA · SHPH
Explorar sector: Healthcare · Medical - Diagnostics & Research
Más secciones de ISPC: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones